Phase i, open-label studies of futibatinib (fbn) excretion, metabolic profiling, and food effects in healthy adult volunteers (havs).
CLINICAL PHARMACOLOGY & THERAPEUTICS(2021)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL PHARMACOLOGY & THERAPEUTICS(2021)